文献速递瓣膜外科

机器人二尖瓣修复项目早期复杂病例的可行性与安全性

Feasibility, safety and quality of complex mitral valve repair in the early phase of a robotic surgery programme.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2024-01-01

该研究回顾了机器人辅助二尖瓣修复项目启动后100例患者,其中21例为复杂修复、79例为非复杂修复。复杂组双叶脱垂、人工腱索和交界成形更多,体外循环和主动脉阻断时间更长,但两组术后4周轻度及以下二尖瓣反流比例、住院时间和不良事件无显著差异。

要点

  • 项目早期复杂机器人二尖瓣修复可行且安全,术后残余反流均≤轻度。
  • 复杂组体外循环、主动脉阻断和瓣叶修复时间更长,二次转机更常见。
  • 复杂组手术室拔管比例更低,但住院时间和不良事件与非复杂组相似。

核心结论

  • 复杂二尖瓣修复在机器人辅助下可安全有效地完成,即使在项目早期阶段。
  • 复杂组手术和通气时间更长,但住院时间和术后不良事件与非复杂组相似。

研究设计与样本

  • 回顾性单中心队列研究,纳入2021年9月至2024年2月共100例机器人辅助二尖瓣修复患者。
  • 复杂修复21例,非复杂修复79例;复杂组中位年龄58岁,非复杂组61岁(P=0.36)。

主要发现

  • 复杂组双叶脱垂比例显著更高(52.4% vs 12.7%,P<0.001)。
  • 复杂组人工腱索置入(61.9% vs 13.9%,P<0.001)和交界成形(28.6% vs 5.1%,P=0.005)更常见。
  • 复杂组体外循环时间(161 vs 141 min,P<0.001)、主动脉阻断时间(123 vs 102 min,P<0.001)和瓣叶修复时间(43 vs 24 min,P<0.001)均更长。
  • 复杂组二次转机比例更高(23.8% vs 3.8%,P=0.01),手术室拔管比例更低(42.9% vs 70.9%,P=0.02)。
  • 两组术后4周轻度及以下二尖瓣反流比例无显著差异(95.2% vs 98.7%,P=0.47)。

关键数值与推荐

  • 所有患者离开手术室时残余二尖瓣反流均为轻度或以下。
  • 复杂组与非复杂组住院时间相似(4 vs 4天,P=0.56)。
  • 两组术后不良事件无显著差异。

临床怎么用

  • 在机器人二尖瓣修复项目早期,可谨慎开展复杂修复,但需预期更长的手术和通气时间。
  • 复杂病例二次转机风险较高,应做好相应预案。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the feasibility, safety and quality of robotic-assisted mitral valve repair in complex versus non-complex cases during the early phase of a programme. METHODS: Since the programme launch in September 2021 until February 2024, 100 patients underwent robotic-assisted mitral valve repair. Of them, 21 patients had complex repairs, while 79 had non-complex repairs. The median age was 58 years for complex cases and 61 years for non-complex cases (P = 0.36). RESULTS: Bileaflet prolapse was significantly more prevalent in the complex group (52.4% vs 12.7%, P < 0.001). Neochord placement (61.9% vs 13.9%, P < 0.001) and commissuroplasty (28.6% vs 5.1%, P = 0.005) were more frequent in the complex group. The complex group had longer cardiopulmonary bypass times (161 vs 141 min, P < 0.001), aortic cross-clamp times (123 vs 102 min, P < 0.001) and leaflet repair times (43 vs 24 min, P < 0.001). Second pump runs were required more often for complex cases (23.8% vs 3.8%, P = 0.01). All patients left the operating room with residual mitral regurgitation of mild or less. Fewer complex patients were extubated in the operating room (42.9% vs 70.9%, P = 0.02), yet hospital stay was similar (4 vs 4 days, P = 0.56). There were no significant differences in postoperative adverse events. There were no differences in mitral regurgitation of mild or less 4 weeks post-surgery (95.2% vs 98.7%, P = 0.47). CONCLUSIONS: Complex mitral valve repair can be safely and effectively performed with robotic assistance, even in the early phase of a programme. Despite longer operative and ventilation times in the complex group, hospital stay and postoperative adverse events remained similar.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kobayashi K, Guo Y, Rubino TE, et al. Feasibility, safety and quality of complex mitral valve repair in the early phase of a robotic surgery programme. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 39558609. doi:10.1093/icvts/ivae182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。